Stockscreener 앱 받기
75.01
0.96%
-0.73
시간 외 거래:
75.01
Alcon Inc 주식(ALC)의 최신 뉴스
Systane Eye Drops Lead Alcon's Shift to Organic Growth After Lensar Deal Collapse - AD HOC NEWS
Alcon and Lensar terminate proposed merger after FTC pressure - Eyes On Eyecare
EV Market: Can Alcon Inc outperform in the next rally2026 Price Targets & Long-Term Growth Stock Strategies - baoquankhu1.vn
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC) - Seeking Alpha
Alcon and Lensar Agree to Terminate Merger Agreement - VisionMonday.com
ACQUISITIONS & MERGERS NEWS: FTC successfully blocks Alcon-LENSAR merger in cataract surgery laser market - VitalLaw.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends - Investing.com
Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360
Alcon abandons effort to purchase LENSAR after FTC scrutiny - MedTech Dive
LENSAR Terminates Merger Agreement with Alcon Following FTC Challenge, Retains $10M Deposit and Announces Strategic Update - Minichart
Lensar Share Slide on Terminated Merger Deal With Alcon - marketscreener.com
Alcon, LENSAR terminate merger agreement after US FTC opposition - MLex
Alcon, LENSAR Halt Merger Deal Amid FTC Scrutiny - Medical Product Outsourcing
US FTC stops proposed merger of Alcon, LENSAR - MLex
US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon - TradingView
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Ends Alcon Merger, Plans Strategic Update - TipRanks
Lensar and Alcon Sign Termination Agreement; Lensar Retains $10 Million Deposit - TradingView
LENSAR (NASDAQ: LNSR) terminates Alcon merger, retains $10M and plans strategy update - Stock Titan
Alcon Inc stock terminates Lensar merger amid US regulatory hurdles, shifts focus to core growth - AD HOC NEWS
Lensar to terminate Alcon merger agreement - Yahoo Finance
Switzerland: Alcon and Lensar agree to terminate merger agreement - Investors in Healthcare
Switzerland's Alcon Abandons Lensar Deal as US Antitrust Hurdles Persist - marketscreener.com
Alcon terminates LENSAR acquisition after FTC opposition By Investing.com - Investing.com Australia
Lensar, Alcon terminate merger after FTC opposition By Investing.com - Investing.com Canada
Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio Leads - Seeking Alpha
Alcon, LENSAR agree to terminate merger agreement - MLex
Lensar agrees to terminate sale to Alcon - MSN
Alcon (ALC) and Lensar Call Off Merger Agreement - GuruFocus
Alcon (ALC) Ends Merger Talks with Lensar, Impacting Both Stocks - GuruFocus
Lensar (LNSR) and Alcon (ALC) Terminate Merger Agreement Amid FT - GuruFocus
Lensar, Alcon terminate merger after FTC opposition - Investing.com
Lensar announces termination of merger agreement with Alcon Research, LLC - marketscreener.com
Alcon terminates LENSAR acquisition after FTC opposition - Investing.com
Lensar® Announces Termination Of Merger Agreement With Alcon Research, Llc - TradingView
Lensar and Alcon Agree to Terminate Merger - marketscreener.com
Alcon and Lensar agree to terminate merger agreement - marketscreener.com
Alcon And Lensar Agree To Terminate Merger Agreement - TradingView
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement - Business Wire
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC - GlobeNewswire
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In - marketscreener.com
Alcon Inc Stock (ISIN: CH0432492467) Eyes 20% Upside as Analysts Weigh Momentum Against Healthcare H - AD HOC NEWS
Alcon Inc Stock (ISIN: CH0432492467) Faces Headwinds Amid Analyst Optimism and Buyback Momentum - AD HOC NEWS
STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash (update) - MSN
Futures Contracts for Alcon Futures - TradingView
Alcon Inc Stock (ISIN: CH0432492467) Holds Steady Amid Eye Care Sector Resilience - AD HOC NEWS
UBS reiterates Buy on Alcon stock, sees earnings beats ahead - Investing.com Nigeria
ALC.SW Alcon Inc. (SIX) closes CHF62.56 on 11 Mar 2026: watch analyst targets - Meyka
RSI Check: Will Alcon Inc benefit from green energy policiesTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn
Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens - MSN
UBS names Alcon top pick, sees strong catalyst path ahead - Investing.com South Africa
UBS reiterates Buy on Alcon stock, sees earnings beats ahead By Investing.com - Investing.com Australia
Alcon Launches Hydrus Microstent in India to Advance Long-Term Glaucoma Management - eHealth Magazine
Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 - marketscreener.com
Stifel Raises Alcon (ALC) Price Target to $82, Maintains 'Hold' Rating | ALC Stock News - GuruFocus
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education - The Manila Times
Bernstein SocGen names Alcon stock top European medtech pick By Investing.com - Investing.com South Africa
3.15%
0.21%
자본화:
|
볼륨(24시간):